Indian Meropenem Exporters: Complete Supplier Ranking with Market Share — 966 Manufacturers (2026) — TransData Nexus

Q: Who is the largest meropenem buyer importing from India?

YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) is the largest meropenem importer from India with a 31.3% market share and import value of $69.8M.

Q: How many meropenem buyers import from India?

There are 966 active meropenem buyers importing from India, with a combined import market of $222.9M across 3,658 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top meropenem buyers from India?

The top 5 meropenem buyers — YUSEN LOGISTICS BENELUX BELGIUM, M/S. SUN PHARMA ANZ PTY LTD, EUGIA US LLC,, VENUS PHARMA GMBH, EUGIA US LLC — together control 52.1% of total meropenem import value from India.

Suresh Sormare

Meropenem

India Pharmaceutical Trade Intelligence

$222.9M401 Suppliers134 CountriesHS 30049099

ExportsIndia → BELGIUM32.0%India → UNITED STATES15.5%

ImportsSWITZERLAND → India$418.3M BELGIUM → India$257.7K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: YUSEN LOGISTICS

Market Analysis: Top Importing Countries & Their Importers

1Belgium

Belgium emerges as the first largest importing country, achieving a total trade value of $71.4M through 143 shipments. This represents a market share of 32.0% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Belgium has a diverse importer base, with their top importers including:

• YUSEN LOGISTICS BENELUX BELGIUM - $69.8M (97.8% of country's total business)

Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $499.2K, indicating premium pricing strategy compared to the market average of $60.9K.

Belgium is a key market for Meropenem imports, representing 32.0% of total trade value.

Primary Market

Secondary Market

2United States

United States emerges as the second largest importing country, achieving a total trade value of $34.6M through 230 shipments. This represents a market share of 15.5% of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Meropenem buyer market intelligence

1Buyer Segment Analysis

The 966 buyers of Meropenem from India can be categorized into several segments:

1. Distributors: Entities that purchase Meropenem in bulk to supply to various healthcare providers.

*Example*: YUSEN LOGISTICS BENELUX BELGIUM (Belgium, $69.84M) likely operates as a distributor, given its substantial purchase volume.

2. Contract Manufacturers: Companies that procure Meropenem as an active pharmaceutical ingredient (API) for formulation into finished products.

*Example*: EUGIA US LLC (United States, $13.78M) and AUROMEDICS PHARMA, LLC (United States, $5.60M) are indicative of this segment, sourcing APIs for their manufacturing processes.

3. Government Procurement Agencies: Organizations responsible for acquiring medicines for public healthcare systems.

*Example*: S T C (Saudi Arabia, $4.39M) and SALEHIYA TRADING COMPANY (Saudi Arabia, $3.80M) may represent government procurement entities, given their significant purchases.

4. Re-exporters: Companies that import Meropenem for the purpose of exporting to other markets.

*Example*: VENUS PHARMA GMBH (Germany, $9.31M) could function as a re-exporter, distributing Meropenem to neighboring regions.

Country-Specific Import Regulations

TransData Nexus Meropenem buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Meropenem are as follows:

1. Belgium

Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP)

Import Registration Process: Requires submission of a marketing authorization application, including quality, safety, and efficacy data.

Estimated Timeline: Approximately 210 days for standard applications.

Import Tariff/Duty: As an EU member, Belgium applies a 0% import duty on pharmaceuticals under HS Code 30049099.

2. United States

Regulatory Authority: U.S. Food and Drug Administration (FDA)

Import Registration Process: Requires an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).

Demand Drivers & Market Opportunity

TransData Nexus Meropenem buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Meropenem in importing countries is driven by several factors:

1. Disease Prevalence: Meropenem is a broad-spectrum antibiotic used to treat severe infections. High incidences of hospital-acquired infections and antimicrobial resistance have increased its utilization.

2. Government Healthcare Programs: Many countries have implemented programs to combat antimicrobial resistance, leading to increased procurement of effective antibiotics like Meropenem.

3. Universal Health Coverage Expansion: Efforts to expand healthcare access have resulted in higher demand for essential medicines. For instance, Australia's Pharmaceutical Benefits Scheme (PBS) subsidizes essential medicines, enhancing affordability and access.

4. WHO Essential Medicines List Procurement: Meropenem's inclusion in the WHO Model List of Essential Medicines encourages its adoption in national formularies, leading to increased procurement.

5. Tender-Based Purchasing: Many governments and large healthcare providers procure medicines through tender processes to ensure cost-effectiveness and supply security. This approach often results in bulk purchasing of antibiotics like Meropenem.

With 966 buyers across 134 countries, the global market for Meropenem from India is substantial. The combination of disease burden, policy initiatives, and procurement strategies continues to drive demand, presenting significant market opportunities for exporters.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Meropenem Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest meropenem buyer importing from India?

Based on import volume and value, YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with $69.8M in imports and a 31.3% market share — the highest of any single meropenem importer. M/S. SUN PHARMA ANZ PTY LTD (AUSTRALIA) and EUGIA US LLC, (UNITED STATES) are the next largest buyers.

QHow many companies buy meropenem from India?

There are 966 active meropenem buyers importing from India, with a combined market of $222.9M across 3,658 shipments to 134 countries. The top 5 buyers hold 52.1% of total import value, while the remaining 961 buyers handle the other 47.9%.

QWhich countries import the most meropenem from India?

The top importing countries for meropenem from India are Belgium (32.0%), United States (15.5%), Australia (8.7%), Germany (6.0%), Saudi Arabia (4.9%). These markets represent the largest demand centres for Indian pharmaceutical exports of meropenem, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for meropenem from India?

The average import transaction value for meropenem from India is $60.9K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.